Psychotic Disorders (cont.)

Medical Author:
Medical Editor:

What are complications and the prognosis of psychotic disorders?

The fact that men seem to develop these illnesses at younger ages may contribute to men having more episodes of the illness that are more severe compared to women. People with a psychotic disorder typically have fewer interactions with peers, tend to prematurely leave school, have low self-esteem, and experience unemployment and substance abuse.

While more than two-thirds of people who have a psychotic disorder may suffer a return of those symptoms at some time, the combination of medications, psychosocial treatment, and education of the psychotic disorder sufferer and their loved ones tends to greatly improve how well the person is able to function. The shorter the amount of time from when the person begins having psychotic symptoms to when comprehensive treatment begins, the better the prognosis.

Is it possible to prevent psychotic disorders?

Cognitive behavioral therapy (CBT) for the person who is at high risk for developing psychosis but has yet to have such symptoms has been found to be more effective than medication at preventing such symptoms. In individuals who have developed psychotic symptoms, providing his or her family with support and education about their loved one's condition have been found to be quite helpful in the prevention of the recurrence of psychotic symptoms in the individual with the illness. For women who have developed postpartum psychosis in the past, preterm delivery of subsequent pregnancy has been found to help prevent further episodes of the disorder.

Where can people find additional information about psychotic disorders?

Action Postpartum Psychosis
Tel: 0292 074 2038

American Psychological Association

American Psychiatric Association

National Alliance for the Mentally Ill (NAMI)

National Mental Health Association

Postpartum Support International

Schizophrenics Anonymous


American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.

Bartholomeusz, C.F., and K. Allott. "Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: Theoretical considerations and current state of evidence." Schizophrenia Research and Treatment, 2012.

Bebbington, P., E. Kuipers, P. Garety, J. Geddes, G. Orbach, and C. Morgan. "Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy." Psychological Medicine 2002; 763-782.

Cannon, T.D., K. Cadenhead, B. Cornblatt, et al. "Prediction of psychosis in youth at high clinical risk." Archives of General Psychiatry 65 (2008): 28-37.

Cobb, C. "Fact Sheet: Clozaril (Clozapine)." National Alliance on Mental Illness Minnesota. Dec. 2006. <>.

Cornblatt, B.A., R.E. Carrion, J. Addington, L. Seidman, E.F. Walker, et al. "Risk factors for psychosis: Impaired social and role functioning." Schizophrenia Bulletin 38.6 (2012): 1247-1257.

Das-Munshi, J., L. Becares, J.E. Boydell, M.E. Dewey, et al. "Ethnic density as a buffer for psychotic experiences: findings from a national survey (EMPIRIC)." British Journal of Psychiatry 201 Oct. 2012: 282-290.

Dvir, Y., and J.A. Frazier. "Autism and schizophrenia." Psychiatric Times 28.3 (2011).

Haddad, P.M., C. Brain, and J. Scott. "Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies." Patient Related Outcome Measures 5 June 23, 2014: 43-62. <>.

Honey, G.D., P.R. Corlett, A.R. Absalom, M. Lee, et al. "Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo." Journal of Neuroscience June 2008: 62-95-6303.

Jenkins, R., F. Njenga, M. Okonji, P. Kigamwa, et al. "Psychotic symptoms in Kenya – prevalence, risk factors, and relationship with common mental disorders." International Journal of Environmental Research in Public Health 9.5 (2012): 1748-1756.

Malone, D.T., M.N. Hill, and T. Rubino. "Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models." British Journal of Pharmacology 160.3 June 2010: 511-522.

Nau, M.L., D.E. McNiel, and R.L. Binder. "Postpartum psychosis and the courts." Journal of the American Academy of Psychiatry and the Law 40.3 Sept. 2012: 318-325.

Nuevo, R., et al. "The continuum of psychotic symptoms in the general population: a cross-national study." Schizophrenia Bulletin 38 (2012): 475-485.

Ochoa, S., J. Usall, J. Cobo, X. Labad, and J. Kulkarni. "Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review." Schizophrenia Research and Treatment, 2012.

Semple, D.M., A.M. McIntosh, and S.M. Lawrie. "Cannabis as a risk factor for psychosis: a systemic review." Journal of Psychopharmacology 19.2 (2005): 187-194.

Shrivastava, A., P.D. McGorry, M. Tsuang, S.W. Woods, et al. "Attenuated psychotic symptoms syndrome as a risk syndrome of psychosis, diagnosis in DSM-V: The debate." Indian Journal of Psychiatry 53.1 Jan.-Mar. 2011: 57-65.

Shy, A. "Psychosis in Children and Adolescents." Psychiatric Research Institute. Mar. 31, 2014. <>.

Sikich, L., J.A. Frazier, j. McClellan, et al. "Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizoaffective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) Study." American Journal of Psychiatry 165.11 Nov. 2008: 1420-1431.

Singh, SP. "Outcome measures in early psychosis: Relevance of duration of untreated psychosis." British Journal of Psychiatry, 2007.

Stafford, M.R., et al. "Early interventions to prevent psychosis: systematic review and meta-analysis." British Medical Journal Jan. 2013: 346.

Suvisaari, J.M., V. Taxell-Lassas, M. Pankakoski, et al. "Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder." Schizophrenia Bulletin, 2012.

Terp, I.M., G. Engholm, H. Møller, and P.B. Mortensen. "A follow-up study of postpartum psychoses: prognosis and risk factors for readmission." Acta Psychiatry of Scandinavia 100 (1999): 40-46.

Valencia, M., F. Juarez, and H. Ortega. "Integrated treatment to achieve functional recovery for first-episode psychosis." Schizophrenia Research and Treatment, 2012.

Varese, F., F. Smeets, M. Drukker, R. Lieverse, et al. "Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective – and cross-sectional cohort studies." Schizophrenia Bulletin, 2012.

Wiles, N.J., S. Zammit, P. Bebbington, N. Singleton, et al. "Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey." British Journal of Psychiatry 188 (2006): 519-526.

Medically Reviewed by a Doctor on 8/12/2015

Patient Comments

Viewers share their comments

Psychotic Disorders - Experience Question: What type of psychotic disorder do you have? Describe your experience.
Psychotic Disorders - Treatments Question: What treatment did you receive for your psychotic disorder?
Psychotic Disorders - Symptoms Question: What were the symptoms of your psychotic disorder?